Shares of Dyne Therapeutics declined after the company commenced an underwritten public offering and said it had secured up to $275 million of debt financing. The stock fell 9.8% to $8.59 on Monday.

The market for new offerings has thawed recently, and everyday investors can participate in IPOs through several different ...

UC Asset LP (OTCQB: UCASU) announced today that the company has filed its first amendment to Form 1A for a secondary ...

A surge of global and domestic capital is chasing secondary deals as early-stage domestic funds are nearing the end of their ...

HONG Kong’s sizzling initial public offering (IPO) market is prompting the Big Four accounting firms to sharply raise their ...

A tougher investment climate in the wake of the pandemic means more business owners are opting for secondary transactions.

"Any transfer of OpenAI equity requires our approval — we did not approve any transfer,” the company said in a statement.

Maynilad Water Services Inc. chairman Manuel V. Pangilinan said two cornerstone investors are keen on securing a significant ...

Robinhood brings tokenized shares in SpaceX and OpenAI to Europe – without the companies' consent. Is this democratization or ...

Whether to invest in Figma will depend on the company's valuation once it goes public. Figma has a number of attractive ...

Meesho, a cost-effective e-commerce platform, has taken a significant step towards going public by filing its confidential ...